These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35916729)

  • 1. Longitudinal monitoring of BKPyV miRNA levels in kidney transplant recipients with BKPyV-related pathology reflects viral DNA levels and remain high in viremia patients after clearance of viral DNA.
    van Doesum WB; Gard L; Knijff LWD; Niesters HGM; van Son WJ; Stegeman CA; van den Berg A; Groen H; van den Born J; Riezebos-Brilman A; Sanders JS
    Transpl Infect Dis; 2022 Dec; 24(6):e13927. PubMed ID: 35916729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection.
    Chen XT; Chen WF; Li J; Deng RH; Huang Y; Yang SC; Chen PS; Jiang TY; Liu HT; Wang CX; Chen LZ; Qiu J; Huang G
    Front Immunol; 2020; 11():1763. PubMed ID: 32973745
    [No Abstract]   [Full Text] [Related]  

  • 3. BK Polyomavirus Micro-RNAs: Time Course and Clinical Relevance in Kidney Transplant Recipients.
    Demey B; Descamps V; Presne C; Helle F; Francois C; Duverlie G; Castelain S; Brochot E
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33672313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.
    Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Mallat MJ; Haasnoot GW; van Zwet EW; Claas EC; de Fijter JW; Kroes AC; Arnold F; Touzé A; Claas FH; Rotmans JI; Feltkamp MC
    Am J Transplant; 2017 Jan; 17(1):161-172. PubMed ID: 27251361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
    Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
    Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
    Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
    Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BK polyomavirus microRNA expression and sequence variation in polyomavirus-associated nephropathy.
    Virtanen E; Seppälä H; Helanterä I; Laine P; Lautenschlager I; Paulin L; Mannonen L; Auvinen P; Auvinen E
    J Clin Virol; 2018 May; 102():70-76. PubMed ID: 29518695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of BKV encoded mature MicroRNAs in kidney transplant patients: Clinical and biologic insights.
    Huang Y; Zeng G; Randhawa PS
    J Clin Virol; 2019 Oct; 119():6-10. PubMed ID: 31422199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of BK viremia by urine viral load in renal transplant patients: An analysis of BK viral load results in paired urine and plasma samples.
    Madden K; Janitell C; Sower D; Yang S
    Transpl Infect Dis; 2018 Oct; 20(5):e12952. PubMed ID: 29896858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantation.
    Ahlenstiel-Grunow T; Pape L
    Pediatr Nephrol; 2020 Apr; 35(4):625-631. PubMed ID: 31858227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of HPyV9 and TSPyV coinfection on the development of BK polyomavirus viremia and associated nephropathy after kidney transplantation.
    van Rijn AL; Wunderink HF; de Brouwer CS; van der Meijden E; Rotmans JI; Feltkamp MCW
    J Med Virol; 2019 Jun; 91(6):1142-1147. PubMed ID: 30624811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyomavirus BK Genome Comparison Shows High Genetic Diversity in Kidney Transplant Recipients Three Months after Transplantation.
    Mineeva-Sangwo O; Martí-Carreras J; Cleenders E; Kuypers D; Maes P; Andrei G; Naesens M; Snoeck R
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion from mycophenolate mofetil to mizoribine in the early stages of BK polyomavirus infection could improve kidney allograft prognosis: a single-center study from China.
    Li P; Cheng D; Wen J; Ni X; Xie K; Li X; Chen J
    BMC Nephrol; 2021 Oct; 22(1):328. PubMed ID: 34600511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Frequency US for BK Polyomavirus-associated Nephropathy after Kidney Transplant.
    Yang D; Zhuang B; Wang Y; Huang G; Xu M; Lin M; Wang W; Huang G; Wang C; Xie X; Xie X
    Radiology; 2022 Aug; 304(2):333-341. PubMed ID: 35503018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BK Polyomavirus bkv-miR-B1-5p: A Stable Micro-RNA to Monitor Active Viral Replication after Kidney Transplantation.
    Demey B; Bentz M; Descamps V; Morel V; Francois C; Castelain S; Helle F; Brochot E
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BK polyomavirus in the urine for follow-up of kidney transplant recipients.
    Brochot E; Descamps V; Handala L; Faucher J; Choukroun G; Helle F; Castelain S; François C; Duverlie G; Touzé A
    Clin Microbiol Infect; 2019 Jan; 25(1):112.e1-112.e5. PubMed ID: 30076973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk factors associated with post-transplantation BKPyV nephropathy and BKPyV DNAemia: a prospective study in kidney transplant recipients.
    Lorant C; Zigmantaviciute J; Ali N; Bonnevier U; Tejde M; von Zur-Mühlen B; Eriksson BM; Bergqvist A; Westman G
    BMC Infect Dis; 2024 Feb; 24(1):245. PubMed ID: 38388351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine Exosomal bkv-miR-B1-5p and BK Virus Nephropathy in Kidney Transplant Recipients.
    Jung SW; Cho WH; Seo JW; Kim YG; Moon JY; Kim JS; Kim CD; Chung BH; Park JB; Kim YH; Lee SH
    J Infect Dis; 2023 May; 227(10):1185-1193. PubMed ID: 36374933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable sources of Bk virus in renal allograft recipients.
    Urbano PRP; Nali LHDS; Oliveira RDR; Sumita LM; Fink MCDDS; Pierrotti LC; Bicalho CDS; David-Neto E; Pannuti CS; Romano CM
    J Med Virol; 2019 Jun; 91(6):1136-1141. PubMed ID: 30680753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.